axel grothey, md, considers the role of circulating tumor dna (ctdna)
Published 5 years ago • 81 plays • Length 1:28
Download video MP4
Download video MP3
Similar videos
-
2:37
axel grothey, md | importance of ctdna and mrd testing
-
2:42
what is circulating tumor dna (ctdna)?
-
1:52
axel grothey, md | patient case using ctdna and mrd testing
-
0:41
2020 west oncology conference - axel grothey, md | life-changing aspects of diagnosis & patient care
-
1:41
circulating tumor dna: enhanced cancer detection | stanford cancer institute
-
3:25
understand ctdna testing
-
24:17
diagnosing a-ttr amyloid heart disease: integrating clinical and imaging findings
-
4:56
cf foundation | protein processing cf mutations, e g , f508del or deltaf508
-
0:58
2020 west oncology conference - axel grothey, md | prognostic factors
-
2:10
axel grothey, md, on the cctg co.26 trial in advanced refractory crc presented at gi 2019
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
3:05
the clinical use of circulating tumor dna in t-cell lymphomas
-
0:47
axel grothey, md, on patient selection & treatment algorithms in 2nd and 3rd line crc
-
1:12
axel grothey, md, on the use of regorafenib in the management of advanced crc
-
0:26
2020 west oncology conference - axel grothey, md | working with patient advocacies
-
28:57
circulating tumor dna as an immunotherapy biomarker
-
10:32
the gi oncologist of the future
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
1:47
dr. axel grothey on the time course of regorafenib-associated adverse events
-
1:55
dr. grothey describes the phase iii correct study
-
3:42
circulating tumor dna tests for early stage cancer diagnosis
-
1:35
dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
Clip.africa.com - Privacy-policy